Funds to be used primarily to advance development of ATH434 in Parkinsonian Disorders –– Capital raising was strongly supported by domestic and ...

Mark Antoniewicz, known as AZ, has been named our Premier League Community Captain, in recognition of his dedication, ...

RuPaul’s Drag Race UK favourites Tia Kofi, Baga Chipz, Danny Beard, Cheryl the Queen, and Michael Marouli will take to the ...

Walmart’s latest brand and logo update has left some social media users baffled. On Jan. 13, the company announced in a press release on its website that it was launching a “comprehensive ...

The National Institutes of Health (NIH) said late Friday it was setting a 15 percent limit on its funding of "indirect," or ...

For four seasons, 98 NFL players volunteered mouth guard sensors that recorded data about their head movements. Their ...

One of the most legendary heavy metal bands of all time is reuniting.

Ozzy Osbourne will reunite with all of the original members of Black Sabbath for the first time in 20 years, in a gig that ...

Black Sabbath have announced their final ever show with vocalist Ozzy Osbourne will take place this summer, marking the first ...

Newronika, the developer of groundbreaking adaptive deep brain stimulation technology, is proud to announce the receipt of an ...

The GLP-1 drug, exenatide, has no positive impact on the movement, symptoms or brain imaging of people with Parkinson's, finds a new study led by UCL researchers.

JOTROL is designed to overcome the historical challenges of resveratrol by significantly enhancing bioavailability while minimizing gastrointestinal side effects. The upcoming Phase 2a trial will ...